The table below shows AbCellera Biologics Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$8.31M
$8.96M
$17.08M
$4.24M
$6.51M
$7.32M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$46.66M
$55.03M
$39.21M
$42.50M
$40.97M
$40.93M
ABCL annual revenue (10-K history)
AbCellera Biologics Inc. reported annual revenue of $75.13M for fiscal year 2025. That is up 160.6% from $28.83M in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $11.61M (FY 2019) to $75.13M. Figures come from the company's audited annual reports as filed with the SEC.
